Safety and Efficacy of Autologous Endothelial Progenitor Cell CD 133 for Therapeutic Angiogenesis (PROGENITOR)
This study has been completed.
Pilar Jimenez Quevedo
Grant from the Spanish Heath Ministry and Fundacion de Mutual Madrileña.
Information provided by (Responsible Party):
Pilar Jimenez Quevedo, Hospital San Carlos, Madrid
First received: June 5, 2008
Last updated: August 4, 2013
Last verified: May 2008
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||February 2012|
|Primary Completion Date:||May 2009 (Final data collection date for primary outcome measure)|